{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:34:40Z","timestamp":1772138080421,"version":"3.50.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Motivation: Identification of altered pathways that are clinically relevant across human cancers is a key challenge in cancer genomics. Precise identification and understanding of these altered pathways may provide novel insights into patient stratification, therapeutic strategies and the development of new drugs. However, a challenge remains in accurately identifying pathways altered by somatic mutations across human cancers, due to the diverse mutation spectrum. We developed an innovative approach to integrate somatic mutation data with gene networks and pathways, in order to identify pathways altered by somatic mutations across cancers.<\/jats:p>\n                  <jats:p>Results: We applied our approach to The Cancer Genome Atlas (TCGA) dataset of somatic mutations in 4790 cancer patients with 19 different types of tumors. Our analysis identified cancer-type-specific altered pathways enriched with known cancer-relevant genes and targets of currently available drugs. To investigate the clinical significance of these altered pathways, we performed consensus clustering for patient stratification using member genes in the altered pathways coupled with gene expression datasets from 4870 patients from TCGA, and multiple independent cohorts confirmed that the altered pathways could be used to stratify patients into subgroups with significantly different clinical outcomes. Of particular significance, certain patient subpopulations with poor prognosis were identified because they had specific altered pathways for which there are available targeted therapies. These findings could be used to tailor and intensify therapy in these patients, for whom current therapy is suboptimal.<\/jats:p>\n                  <jats:p>Availability and implementation: The code is available at: http:\/\/www.taehyunlab.org.<\/jats:p>\n                  <jats:p>Contact: \u00a0jhcheong@yuhs.ac or taehyun.hwang@utsouthwestern.edu or taehyun.cs@gmail.com<\/jats:p>\n                  <jats:p>Supplementary information: \u00a0Supplementary data are available at Bioinformatics online.<\/jats:p>","DOI":"10.1093\/bioinformatics\/btv692","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T20:49:46Z","timestamp":1449175786000},"page":"1643-1651","source":"Crossref","is-referenced-by-count":19,"title":["An integrative somatic mutation analysis to identify pathways linked with survival outcomes across 19 cancer types"],"prefix":"10.1093","volume":"32","author":[{"given":"Sunho","family":"Park","sequence":"first","affiliation":[{"name":"1 Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Jun","family":"Kim","sequence":"additional","affiliation":[{"name":"2 Department of Computer Science and Electrical Engineering, University of Maryland at Baltimore County, Baltimore, MD, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghyeon","family":"Yu","sequence":"additional","affiliation":[{"name":"3 Department of Statistics, Keimyung University, Daegu, South Korea,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Pe\u00f1a-Llopis","sequence":"additional","affiliation":[{"name":"4 Internal Medicine and"},{"name":"5 Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjiong","family":"Gao","sequence":"additional","affiliation":[{"name":"6 Center for Molecular Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Suk","family":"Park","sequence":"additional","affiliation":[{"name":"1 Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beibei","family":"Chen","sequence":"additional","affiliation":[{"name":"1 Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessie","family":"Norris","sequence":"additional","affiliation":[{"name":"1 Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlei","family":"Wang","sequence":"additional","affiliation":[{"name":"7 Department of Statistical Science, Southern Methodist University, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[{"name":"8 Department of Mathematical Sciences, University of Texas at Dallas, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minsoo","family":"Kim","sequence":"additional","affiliation":[{"name":"1 Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeongsik","family":"Yong","sequence":"additional","affiliation":[{"name":"9 Department of Biochemistry, Molecular Biology and Biophysics, Obstetrics, Gynecology & Women\u2019s Health, University of Minnesota Twin Cities, Minneapolis, MN, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zabi","family":"Wardak","sequence":"additional","affiliation":[{"name":"5 Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA,"},{"name":"10 Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Choe","sequence":"additional","affiliation":[{"name":"5 Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA,"},{"name":"10 Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Story","sequence":"additional","affiliation":[{"name":"5 Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA,"},{"name":"10 Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Starr","sequence":"additional","affiliation":[{"name":"11 Genetics, Cell Biology, University of Minnesota Twin Cities, Minneapolis, MN, USA,"},{"name":"12 Masonic Cancer Center, University of Minnesota Twin Cities, Minneapolis, MN, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Ho","family":"Cheong","sequence":"additional","affiliation":[{"name":"13 Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea and"},{"name":"14 Open NBI Convergence Technology Research Laboratory, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Hyun","family":"Hwang","sequence":"additional","affiliation":[{"name":"1 Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA,"},{"name":"5 Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"key":"2023020112291212200_btv692-B1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1634\/theoncologist.2011-S1-12","article-title":"Targeting the phosphoinositide-3 (pi3) kinase pathway in breast cancer","volume":"16","author":"Baselga","year":"2011","journal-title":"Oncologist"},{"key":"2023020112291212200_btv692-B2","doi-asserted-by":"crossref","first-page":"e8918","DOI":"10.1371\/journal.pone.0008918","article-title":"Automated network analysis identifies core pathways in glioblastoma","volume":"5","author":"Cerami","year":"2010","journal-title":"PLoS One"},{"key":"2023020112291212200_btv692-B3","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1137\/110859063","article-title":"On tensors, sparsity, and nonnegative factorizations","volume":"33","author":"Chi","year":"2012","journal-title":"SIAM J. Matrix Anal. Appl."},{"key":"2023020112291212200_btv692-B4","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1101\/gr.134635.111","article-title":"Music: identifying mutational significance in cancer genomes","volume":"22","author":"Dees","year":"2012","journal-title":"Genome Res."},{"key":"2023020112291212200_btv692-B5","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcription elongation by the vhl tumor suppressor protein","volume":"269","author":"Duan","year":"1995","journal-title":"Science"},{"key":"2023020112291212200_btv692-B6","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"Cosmic: exploring the world\u2019s knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2023020112291212200_btv692-B7","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cbioportal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"2023020112291212200_btv692-B8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2013.03.002","article-title":"Lessons from the cancer genome","volume":"153","author":"Garraway","year":"2013","journal-title":"Cell"},{"key":"2023020112291212200_btv692-B9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J."},{"key":"2023020112291212200_btv692-B10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cncr.23545","article-title":"Phase ii trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck","volume":"113","author":"Gilbert","year":"2008","journal-title":"Cancer"},{"key":"2023020112291212200_btv692-B11","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nmeth.2651","article-title":"Network-based stratification of tumor mutations","volume":"10","author":"Hofree","year":"2013","journal-title":"Nat. Methods"},{"key":"2023020112291212200_btv692-B12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/1471-2164-14-440","article-title":"Large-scale integrative network-based analysis identifies common pathways disrupted by copy number alterations across cancers","volume":"14","author":"Hwang","year":"2013","journal-title":"BMC Genomics"},{"key":"2023020112291212200_btv692-B13","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1093\/nar\/gks615","article-title":"Co-clustering phenomegenome for phenotype classification and disease gene discovery","volume":"40","author":"Hwang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"2023020112291212200_btv692-B14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.bjc.6601897","article-title":"Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer","volume":"91","author":"Jones","year":"2004","journal-title":"Br. J. Cancer"},{"key":"2023020112291212200_btv692-B15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"2023020112291212200_btv692-B16","doi-asserted-by":"crossref","first-page":"D767","DOI":"10.1093\/nar\/gkn892","article-title":"Human protein reference database2009 update","volume":"37","author":"Keshava Prasad","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"2023020112291212200_btv692-B29","first-page":"1","article-title":"Sparse robust matrix tri-factorization with application to cancer genomics","volume-title":"Proceeding of 3rd International workshop on Cognitive Information Processing","author":"Kim","year":"2012"},{"key":"2023020112291212200_btv692-B17","doi-asserted-by":"crossref","first-page":"e11584","DOI":"10.1371\/journal.pone.0011584","article-title":"Lrp-1 promotes cancer cell invasion by supporting erk and inhibiting jnk signaling pathways","volume":"5","author":"Langlois","year":"2010","journal-title":"PLoS One"},{"key":"2023020112291212200_btv692-B18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"2023020112291212200_btv692-B19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"2023020112291212200_btv692-B20","first-page":"556","article-title":"Algorithms for non-negative matrix factorization","volume-title":"Advances in Neural Information Processing Systems 13","author":"Lee","year":"2001"},{"key":"2023020112291212200_btv692-B21","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-07-4921","article-title":"Improved identification of von hippel-lindau gene alterations in clear cell renal tumors","volume":"14","author":"Nickerson","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"2023020112291212200_btv692-B22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxia-inducible factor requires direct binding to the [bgr]-domain of the von hippel-lindau protein","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"2023020112291212200_btv692-B23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1254\/jphs.08174FP","article-title":"Captopril attenuates matrix metalloproteinase-2 and -9 in monocrotaline-induced right ventricular hypertrophy in rats","volume":"108","author":"Okada","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"2023020112291212200_btv692-B24","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1101\/gr.173039.114","article-title":"Linking signaling pathways to transcriptional programs in breast cancer","volume":"24","author":"Osmanbeyoglu","year":"2014","journal-title":"Genome Res."},{"key":"2023020112291212200_btv692-B25","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/nprot.2013.141","article-title":"Simultaneous isolation of high-quality dna, rna, mirna and proteins from tissues for genomic applications","volume":"8","author":"Pe\u00f1a-Llopis","year":"2013","journal-title":"Nat. Protocol."},{"key":"2023020112291212200_btv692-B26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"Bap1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pe\u00f1a-Llopis","year":"2012","journal-title":"Nat. Genet."},{"key":"2023020112291212200_btv692-B27","doi-asserted-by":"crossref","first-page":"e1001273","DOI":"10.1371\/journal.pgen.1001273","article-title":"Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology","volume":"7","author":"Rossin","year":"2011","journal-title":"PLoS Genet."},{"key":"2023020112291212200_btv692-B28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat. Genet."},{"key":"2023020112291212200_btv692-B30","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1158\/0008-5472.CAN-12-4233","article-title":"Myeloid cell receptor lrp1\/cd91 regulates monocyte recruitment and angiogenesis in tumors","volume":"73","author":"Staudt","year":"2013","journal-title":"Cancer Res."},{"key":"2023020112291212200_btv692-B31","first-page":"442","article-title":"Interaction of topotecan\u2014a dna topoisomerase I inhibitor\u2013with dual-stranded polydeoxyribonucleotides. ii. Formation of a complex containing several dna molecules in the presence of topotecan","volume":"35","author":"strel\u2019tsov","year":"2001","journal-title":"Mol. Biol. (Mosk)"},{"key":"2023020112291212200_btv692-B32","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"2023020112291212200_btv692-B33","doi-asserted-by":"crossref","first-page":"e1000662","DOI":"10.1371\/journal.pcbi.1000662","article-title":"Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets","volume":"6","author":"Suthram","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"2023020112291212200_btv692-B34","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1038\/srep02650","article-title":"Comprehensive identification of mutational cancer driver genes across 12 tumor types","volume":"3","author":"Tamborero","year":"2013","journal-title":"Sci. Rep."},{"key":"2023020112291212200_btv692-B35","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","article-title":"Mechanism of regulation of the hypoxia-inducible factor-1a by the von Hippel-Lindau tumor suppressor protein","volume":"19","author":"Tanimoto","year":"2000","journal-title":"EMBO J."},{"key":"2023020112291212200_btv692-B36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"The Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"2023020112291212200_btv692-B37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/cmb.2010.0265","article-title":"Algorithms for detecting significantly mutated pathways in cancer","volume":"18","author":"Vandin","year":"2011","journal-title":"J. Comput. Biol."},{"key":"2023020112291212200_btv692-B38","doi-asserted-by":"crossref","first-page":"i237","DOI":"10.1093\/bioinformatics\/btq182","article-title":"Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using paradigm","volume":"26","author":"Vaske","year":"2010","journal-title":"Bioinformatics"},{"key":"2023020112291212200_btv692-B39","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ejso.2005.04.003","article-title":"Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in\u00a0vitro and murine models","volume":"31","author":"Williams","year":"2005","journal-title":"Eur. J. Surg. Oncol."},{"key":"2023020112291212200_btv692-B40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejphar.2008.04.031","article-title":"Inhibitory profiles of captopril on matrix metalloproteinase-9 activity","volume":"588","author":"Yamamoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"2023020112291212200_btv692-B41","doi-asserted-by":"crossref","first-page":"i401","DOI":"10.1093\/bioinformatics\/btr206","article-title":"A novel computational framework for simultaneous integration of multiple types of genomic data to identify microrna-gene regulatory modules","volume":"27","author":"Zhang","year":"2011","journal-title":"Bioinformatics"},{"key":"2023020112291212200_btv692-B42","doi-asserted-by":"crossref","first-page":"e1002975","DOI":"10.1371\/journal.pcbi.1002975","article-title":"Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment","volume":"9","author":"Zhang","year":"2013","journal-title":"PLoS Comput. Biol."}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/32\/11\/1643\/49019417\/bioinformatics_32_11_1643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/32\/11\/1643\/49019417\/bioinformatics_32_11_1643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T17:33:04Z","timestamp":1675272784000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/32\/11\/1643\/1742725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,3]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btv692","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/017582","asserted-by":"object"}]},"ISSN":["1367-4811","1367-4803"],"issn-type":[{"value":"1367-4811","type":"electronic"},{"value":"1367-4803","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,6,1]]},"published":{"date-parts":[[2015,12,3]]}}}